Emily Freund is a principal scientist specializing in nucleic acid technology, with sixteen years of research experience focusing on mRNA therapeutics, cancer immunology, and gene expression regulation. Currently, they lead technology efforts at Genentech, having previously held various scientific and instructional roles at prestigious institutions, including Stanford University and UC Berkeley. They earned a PhD in Molecular and Cell Biology from the University of California, Berkeley, and a Bachelor of Arts in Biology from Carleton College. Emily is recognized for their expertise in RNA/DNA vaccine design, biochemical screening, and CRISPR/Cas9 techniques.
This person is not in the org chart
This person is not in any teams
This person is not in any offices